CIM Investment Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $667K | Sell |
7,699
-37
| -0.5% | -$3.54K | 0.18% | 97 |
|
|
2025
Q4 | $743K | Hold |
7,736
| – | – | 0.19% | 90 |
|
|
2025
Q3 | $737K | Sell |
7,736
-7,939
| -51% | -$730K | 0.2% | 87 |
|
|
2025
Q2 | $1.31M | Buy |
15,675
+7,822
| +100% | +$663K | 0.25% | 85 |
|
|
2025
Q1 | $706K | Sell |
7,853
-5
| -0.1% | -$447 | 0.16% | 89 |
|
|
2024
Q4 | $628K | Buy |
7,858
+35
| +0.4% | +$3.03K | 0.18% | 99 |
|
|
2024
Q3 | $704K | Sell |
7,823
-141
| -2% | -$11.9K | 0.21% | 92 |
|
|
2024
Q2 | $627K | Sell |
7,964
-47
| -0.6% | -$3.85K | 0.19% | 103 |
|
|
2024
Q1 | $698K | Hold |
8,011
| – | – | 0.21% | 100 |
|
|
2023
Q4 | $660K | Hold |
8,011
| – | – | 0.21% | 97 |
|
|
2023
Q3 | $628K | Sell |
8,011
-194
| -2% | -$16.2K | 0.23% | 95 |
|
|
2023
Q2 | $723K | Buy |
8,205
+21
| +0.3% | +$1.81K | 0.25% | 86 |
|
|
2023
Q1 | $660K | Buy |
8,184
+402
| +5% | +$32.8K | 0.24% | 93 |
|
|
2022
Q4 | $605K | Sell |
7,782
-223
| -3% | -$18.1K | 0.24% | 91 |
|
|
2022
Q3 | $646K | Hold |
8,005
| – | – | 0.29% | 69 |
|
|
2022
Q2 | $718K | Sell |
8,005
-44
| -0.5% | -$4.46K | 0.3% | 69 |
|
|
2022
Q1 | $893K | Sell |
8,049
-10
| -0.1% | -$1.06K | 0.3% | 74 |
|
|
2021
Q4 | $834K | Sell |
8,059
-158
| -2% | -$18.3K | 0.25% | 82 |
|
|
2021
Q3 | $1.03M | Sell |
8,217
-49
| -0.6% | -$6.34K | 0.32% | 60 |
|
|
2021
Q2 | $1.03M | Sell |
8,266
-45
| -0.5% | -$5.65K | 0.32% | 63 |
|
|
2021
Q1 | $982K | Sell |
8,311
-323
| -4% | -$37.9K | 0.31% | 56 |
|
|
2020
Q4 | $1.01M | Sell |
8,634
-142
| -2% | -$15.6K | 0.33% | 56 |
|
|
2020
Q3 | $912K | Sell |
8,776
-96
| -1% | -$9.64K | 0.35% | 52 |
|
|
2020
Q2 | $814K | Hold |
8,872
| – | – | 0.33% | 55 |
|
|
2020
Q1 | $800K | Sell |
8,872
-890
| -9% | -$94.7K | 0.39% | 44 |
|
|
2019
Q4 | $1.11M | Hold |
9,762
| – | – | 0.44% | 36 |
|
|
2019
Q3 | $1.06M | Sell |
9,762
-959
| -9% | -$100K | 0.4% | 34 |
|
|
2019
Q2 | $1.04M | Buy |
10,721
+2,765
| +35% | +$252K | 0.38% | 45 |
|
|
2019
Q1 | $725K | Buy |
+7,956
| New | +$712K | 0.28% | 72 |
|
|
2017
Q3 | – | Sell |
-3,443
| Closed | -$306K | – | 339 |
|
|
2017
Q2 | $306K | Hold |
3,443
| – | – | 0.11% | 270 |
|
|
2017
Q1 | $277K | Hold |
3,443
| – | – | 0.1% | 278 |
|
|
2016
Q4 | $245K | Hold |
3,443
| – | – | 0.09% | 300 |
|
|
2016
Q3 | $297K | Buy |
+3,443
| New | +$300K | 0.11% | 248 |
|
Other funds holding MDT
CIM Investment Management's MDT Position: Q1 2026 in Review
CIM Investment Management reduced its Medtronic (MDT) stake by 0.48% in Q1 2026, selling an estimated $3.54K and leaving 7,699 shares worth $667K. The position accounts for 0.18% of the portfolio, ranked #97.
CIM Investment Management first reported a position in MDT in Q3 2016 and has held it in 33 quarters since. The position peaked at $1.31M in Q2 2025. 2,244 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- CIM Investment Management held 7,699 shares of Medtronic worth $667K as of Q1 2026.
- CIM Investment Management sold 37 Medtronic shares in Q1 2026, an estimated $3.54K.
- Medtronic made up 0.18% of CIM Investment Management's portfolio in Q1 2026, its #97 holding.
- CIM Investment Management first reported a position in Medtronic in Q3 2016 and has held it in 33 quarters since.
- CIM Investment Management's Medtronic position peaked at $1.31M in Q2 2025.
- 2,244 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on CIM Investment Management's 13F filing for Q1 2026, filed 19 May 2026.